Alive | Death | t/x2 | P value | |||
Operation Done | N | % | N | % |
|
|
CRS | 1 | 20.00 | 4 | 80.00 | 7.106 | 0.130 |
CRS + HIPEC | 8 | 66.67 | 4 | 33.33 | ||
Inoperable | 3 | 50.00 | 3 | 50.00 | ||
aborted | 0 | 0.00 | 3 | 100.00 | ||
Lap. Exploration | 1 | 100.00 | 0 | 0.00 | ||
Age (Range, Mean ± SD) |
| 25 - 61 47.42 ± 10.95 |
| 45 - 70 59.95 ± 9.73 | −3.782 | 0.001* |
Time Interval (N, %) | N | % | N | % |
|
|
1 to 6 | 9 | 45.00 | 11 | 55.00 | 2.205 | 0.332 |
6 to 12 | 2 | 66.67 | 1 | 33.33 |
|
|
>12. | 0 | 0.00 | 2 | 100.00 |
|
|
Path Grade (N, %) | N | % | N | % |
|
|
Low | 17 | 56.67 | 13 | 43.33 | 3.288 | 0.070 |
High | 2 | 22.22 | 7 | 77.78 |
|
|
Total | 19 | 48.72 | 20 | 51.28 |
|
|
Operation + grade (N, %) | N | % | N | % |
|
|
CRS + HIPEC with Low grade tumor | 8 | 80.00 | 2 | 20.00 | 4.800 | 0.028* |
CRS + HIPEC with High grate tumor | 0 | 0.00 | 2 | 100.00 |
|
|
Number of elevated markers (N, %) | N | % | N | % |
|
|
No | 4 | 57.14 | 3 | 42.86 | 0.152 | 0.985 |
One | 5 | 62.50 | 3 | 37.50 |
|
|
Two | 4 | 66.67 | 2 | 33.33 |
|
|
Three | 2 | 66.67 | 1 | 33.33 |
|
|
Total | 15 | 62.50 | 9 | 37.50 |
|
|